Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare ConferenceGlobeNewsWire • 08/31/21
Akoya Biosciences, Inc. (AKYA) CEO Brian McKelligon on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of CancerGlobeNewsWire • 07/19/21
Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I2) NetworkGlobeNewsWire • 06/29/21
Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of DirectorsGlobeNewsWire • 06/25/21
Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping CapabilitiesGlobeNewsWire • 06/15/21
Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy and PathologyGlobeNewsWire • 06/10/21
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune BiologyGlobeNewsWire • 06/04/21
Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical ApplicationsGlobeNewsWire • 06/02/21
Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 GuidanceGlobeNewsWire • 05/18/21
Akoya Biosciences Begins Accepting Applications for First-of-its-Kind Imaging Innovators (I²) NetworkGlobeNewsWire • 05/11/21
DLA Piper advises Akoya Biosciences in its US$151 million initial public offeringPRNewsWire • 05/03/21
Akoya Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 04/20/21